Webinar: How do you patent healthcare AI?
Judging by today’s news cycle, you might think that the world of IP is quite advanced when it comes to artificial intelligence .
Argentum can't bring Gilenya patent challenge
Argentum Pharmaceuticals can’t have a Novartis patent for a multiple sclerosis drug invalidated because it doesn’t have standing to bring the challenge, the US Court of Appeals for the Federal Circuit has ruled.
Pfizer fails to establish standing for patent challenge
Pfizer has been rebuked by judges for filing thin evidence in support of what the pharma company called its ‘self-evident’ standing to bring a patent challenge.
3M secures restraining order in face mask price-gouging suit
3M has convinced a US judge to grant a restraining order against a New Jersey company it has accused of infringing the 3M trademarks by reselling N95 masks at “grossly inflated” prices amid the COVID-19 pandemic.
Akebia prevails over Fibrogen in UK patent suit
Massachusetts-based pharmaceutical company Akebia has had five Fibrogen patents for an anaemia treatment invalidated at the English High Court.
Sports nutrition company sues NASCAR driver over TMs
NASCAR driver Caesar Bacarella’s sports clothing line and supplement business have been hit with a lawsuit by an Australia company.
Fed Circuit rejects Biogen’s plea in MS drug dispute
The US Court of Appeals for the Federal Circuit has affirmed a lower court’s decision which found that Banner Life Sciences wasn’t infringing a Biogen patent with its bioequivalent version of a multiple sclerosis drug.
OECD and Europol issue COVID-19 counterfeits warning
The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the OECD and EUIPO.
World’s scientists working on nearly 80 COVID-19 vaccines
A total of 79 vaccines and 155 drugs are currently being developed across the globe to combat COVID-19, according to statistics from the Austrian Institute for Health Technology Assessment.
Fed Circuit resuscitates heart monitoring patent
The US Court of Appeals for the Federal Circuit has overturned a lower court’s decision to find a heart monitoring patent invalid under Alice, handing a win to medical laboratory company BioTelemetry.
